Mangoceuticals, Inc. Earnings Per Share (Basic)
Mangoceuticals, Inc. (MGRX) reported Earnings Per Share (Basic) of -$0.09 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- Mangoceuticals, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.09.
- Mangoceuticals, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.22.
- Mangoceuticals, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.22.
- Mangoceuticals, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.69.
- Mangoceuticals, Inc. earnings per share, basic for fiscal 2025 was -$2.17.
- Mangoceuticals, Inc. earnings per share, basic for fiscal 2024 was -$4.80.
- Mangoceuticals, Inc. earnings per share, basic for fiscal 2023 was -$8.58.
- Mangoceuticals, Inc. earnings per share, basic for fiscal 2022 was -$0.19.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.09 10-Q · filed 2026-08-13 | -$0.32 10-Q · filed 2026-08-13 | -$0.53 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$1.10 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2026-03-31 | -$0.22 10-Q · filed 2026-05-19 | -$0.44 derived: net income ÷ weighted average shares · filed 2026-05-19 | -$1.04 derived: net income ÷ weighted average shares · filed 2026-05-19 | -$1.56 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-12-31 | -$0.22 derived: net income ÷ weighted average shares · filed 2026-04-01 | -$0.85 derived: net income ÷ weighted average shares · filed 2026-04-01 | -$1.40 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$2.17 10-K · filed 2026-04-01 | ||||
| 2025-09-30 | -$0.69 10-Q · filed 2025-11-14 | -$1.27 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$2.16 10-Q · filed 2025-11-14 | -$2.88 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-06-30 | -$0.57 10-Q · filed 2026-08-13 | -$1.49 10-Q · filed 2026-08-13 | -$1.60 10-Q · filed 2025-08-14 | -$2.23 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$3.14 derived: net income ÷ weighted average shares · filed 2026-08-13 | |||
| 2025-03-31 | -$1.12 10-Q · filed 2026-05-19 | -$1.29 10-Q · filed 2025-05-15 | -$1.96 derived: net income ÷ weighted average shares · filed 2026-05-19 | -$3.05 derived: net income ÷ weighted average shares · filed 2026-05-19 | ||||
| 2024-12-31 | -$0.74 derived: net income ÷ weighted average shares · filed 2026-04-01 | -$1.83 derived: net income ÷ weighted average shares · filed 2026-04-01 | -$4.80 10-K · filed 2026-04-01 | -$4.84 10-K · filed 2025-03-20 | ||||
| 2024-09-30 | -$1.14 10-Q · filed 2025-11-14 | -$0.99 10-Q · filed 2024-11-14 | -$4.28 10-Q · filed 2025-11-14 | -$3.83 10-Q · filed 2024-11-14 | ||||
| 2024-06-30 | -$1.37 10-Q/A · filed 2025-11-14 | -$0.09 10-Q · filed 2024-08-14 | -$2.90 10-Q/A · filed 2025-11-14 | -$0.19 10-Q · filed 2024-08-14 | ||||
| 2024-03-31 | -$1.50 10-Q · filed 2025-05-15 | -$0.10 10-Q · filed 2024-05-15 | ||||||
| 2023-12-31 | -$8.58 10-K · filed 2025-03-20 | -$0.57 10-K · filed 2024-04-01 | ||||||
| 2023-09-30 | -$1.70 10-Q · filed 2024-11-14 | -$0.11 10-Q · filed 2023-10-27 | -$6.68 10-Q · filed 2024-11-14 | -$0.45 10-Q · filed 2023-10-27 | ||||
| 2023-06-30 | -$0.14 10-Q · filed 2024-08-14 | -$0.33 10-Q · filed 2024-08-14 | ||||||
| 2023-03-31 | -$0.23 10-Q · filed 2024-05-15 | |||||||
| 2022-12-31 | -$0.19 10-K · filed 2024-04-01 | |||||||
| 2022-09-30 | -$0.10 10-Q · filed 2023-10-27 | -$0.13 10-Q · filed 2023-10-27 | ||||||
| 2022-06-30 | -$0.04 10-Q · filed 2023-07-28 | -$0.04 10-Q · filed 2023-07-28 | ||||||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |